Antimicrobial Resistance Surveillance Market worth $8.71 billion by 2030, growing at a CAGR of 6.49% - Exclusive Report by 360iResearch

The "Antimicrobial Resistance Surveillance Market by Component (Diagnostic Kits, Diagnostic Systems, Services), End-User (Hospitals, Research & Academic Institutes) - Global Forecast 2024-2030" report has been added to 360iResearch.com's offering.

The Global Antimicrobial Resistance Surveillance Market to grow from USD 5.60 billion in 2023 to USD 8.71 billion by 2030, at a CAGR of 6.49%.

Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/antimicrobial-resistance-surveillance?utm_source=openpr&utm_medium=referral&utm_campaign=sample

The antimicrobial resistance surveillance market encompasses products to monitor, analyze, and control the spread of microorganisms that develop resistance to antibiotics, antivirals, antifungals, and other antimicrobial agents. The primary application of antimicrobial resistance surveillance is to provide information on the prevalence of resistant pathogens in various settings such as hospitals, community health centers, food production facilities, animal husbandry operations, water treatment plants, and environmental samples. The increasing prevalence of multidrug-resistant organisms worldwide necessitates constant monitoring to adapt existing treatments appropriately. Advances in molecular diagnostics techniques enable early detection and identification of antibiotic-resistant strains. Addtionally, growing awareness about antibiotic stewardship programs among healthcare professionals encourages prudent prescribing practices. Despite the growth prospects, several challenges hinder the antimicrobial resistance surveillance market progress. Inadequate infrastructure and funding in low and middle-income countries result in limited surveillance capabilities. Variability in laboratory methodologies employed worldwide hampers comparability of results across regions. However, the emergence of point-of-care testing devices expedites diagnosis and enables personalized treatment decisions. Harnessing genomic sequencing technologies allows for accurate tracking of resistance mechanisms and transmission dynamics at a population level. Along with these, to sustain business growth and contribute to global health security, stakeholders should focus on key areas like refining diagnostic tools for faster detection, exploring unconventional treatment approaches, utilizing artificial intelligence for predictive modeling.

Antimicrobial resistance (AMR) has emerged as a significant public health threat across the Americas and Europe. Continuous surveillance of AMR is crucial in understanding the growing impact on healthcare systems, guiding policy decisions, and implementing effective strategies to mitigate the risks associated with resistant infections. The major driving factors behind increased AMR levels in the Americas and Europe include the overuse and misuse of antimicrobials in human medicine, veterinary practice, agriculture, and food production sectors. In developed countries across the Americas and Europe, stringent regulatory frameworks govern the actions of manufacturers and providers of antimicrobial products. The potential associated with emerging countries in addressing AMR is immense due to factors such as rapid economic growth, increasing healthcare expenditure, and favorable government policies. Emerging economies like India, China, and Brazil are investing heavily in R&D for antimicrobial resistance surveillance and promoting public-private partnerships to address the issue. Governments provide financial support for research and development (R&D) efforts to incentivize innovation in addressing antimicrobial resistance. For instance, in August 2023, the UK government made a significant investment of £210 million to enhance global surveillance of drug-resistant bacteria, a critical aspect of Antimicrobial Resistance (AMR) surveillance. However, initiatives focusing on surveillance systems enhancement, regulatory oversight improvements, investment in research, and development of new treatments are crucial to combating this threat effectively.

Market Segmentation & Coverage:

This research report categorizes the Antimicrobial Resistance Surveillance Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Diagnostic Kits, Diagnostic Systems, Services, and Software. The Diagnostic Systems is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals and Research & Academic Institutes. The Research & Academic Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.48% in 2023, followed by Europe, Middle East & Africa.

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/antimicrobial-resistance-surveillance?utm_source=openpr&utm_medium=referral&utm_campaign=inquire

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Antimicrobial Resistance Surveillance Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in the Antimicrobial Resistance Surveillance Market. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Key Company Profiles:

The report delves into recent significant developments in the Antimicrobial Resistance Surveillance Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accelerate Diagnostics, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., Liofilchem S.r.l., Lumed, Luminex Corporation, Merck & Co., Inc., Novo Holdings A/S, OpGen, Inc., Pfizer Inc., QIAGEN GmbH, Sanofi S.A., Thermo Fisher Scientific Inc., Venatorx Pharmaceuticals, Inc., Viatris Inc., Vivli Inc., and Wolters Kluwer N.V..

Key Topics Covered:

1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Antimicrobial Resistance Surveillance Market, by Component
7. Antimicrobial Resistance Surveillance Market, by End-User
8. Americas Antimicrobial Resistance Surveillance Market
9. Asia-Pacific Antimicrobial Resistance Surveillance Market
10. Europe, Middle East & Africa Antimicrobial Resistance Surveillance Market
11. Competitive Landscape
12. Competitive Portfolio

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Antimicrobial Resistance Surveillance Market?
2. Which are the products/segments/applications/areas to invest in over the forecast period in the Antimicrobial Resistance Surveillance Market?
3. What is the competitive strategic window for opportunities in the Antimicrobial Resistance Surveillance Market?
4. What are the technology trends and regulatory frameworks in the Antimicrobial Resistance Surveillance Market?
5. What is the market share of the leading vendors in the Antimicrobial Resistance Surveillance Market?
6. What modes and strategic moves are considered suitable for entering the Antimicrobial Resistance Surveillance Market?

Read More @ https://www.360iresearch.com/library/intelligence/antimicrobial-resistance-surveillance?utm_source=openpr&utm_medium=referral&utm_campaign=analyst

Contact 360iResearch

Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550

About 360iResearch

360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

This release was published on openPR.